LP-105

N/A

Report date: 2022/10/19 11:35:13

Base Information

Drug NameLP-105
Drug Alias NameLP-105
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Lintonpharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Lintonpharm Co Ltd
Inactive CompaniesN/A
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A